Nello Mainolfi sold $3.4M of KYMR stock

Nello Mainolfi, Chief Executive Officer of Kymera Therapeutics, Inc. (KYMR), sold 30,000 shares of KYMR stock worth $3.4M, per an SEC Form 4 filed Oct 1, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade was reported on Oct 1, 2026.

KYMR has moved +15.5% since the trade date, from $110.12 to $127.17 (Nov 12, 2026 close).